Fig. 4
From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
METTL7B expression is positively correlated with immune cell infiltration in cancers. A BRCA. B LGG. C PRAD
Fig. 4 | Cancer Cell International